Vision | Free Full-Text | New Therapies of Neovascular AMD—Beyond Anti-VEGFs | HTML
Pegaptanib sodium | Nature Reviews Drug Discovery
Aptamers as a promising approach for the control of parasitic diseases
Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence - Kidney International
Pegaptanib for Neovascular Age-Related Macular Degeneration | NEJM
Pegaptanib structure and target binding.a | Sequence and predicted... | Download Scientific Diagram
AMD: New Therapies, New Mechanisms
Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies - American Journal of Ophthalmology
Pegaptanib | owlapps
JaypeeDigital | eBook Reader
Pegaptanib - Wikipedia
JaypeeDigital | eBook Reader
Macugen (Pegaptanib Sodium): Uses, Dosage, Side Effects, Interactions, Warning
13 Pharmacokinetics of Anti-Vascular Endothelium Growth Factor Pharmacological Agents | Ento Key
Mechanism of action of intravitreal antiangiogenic drugs. Angiogenic... | Download Scientific Diagram
Frontiers | RNA Therapeutics in Cardiovascular Precision Medicine | Physiology
Anti-VEGF Therapy: Basics and Substances | SpringerLink
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. - Abstract - Europe PMC
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy | Diabetes Care
Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases - ScienceDirect
Pegaptanib - Wikipedia
Retinal Physician - The State of Gene Therapy With Viral Vectors for AMD
New Treatments for Age Related Macular Degeneration: The Role of AntiAngiogenic Agents in the Treatment of Choroidal Neovascular Membrane - A Case of Recurrent Membrane
